Measure Name:
Appropriate dosages of H2 blockers in patients with CrCl < 50 ml/min
QCDR Measure ID:
CLLC6
QCDR Measure Type:
New QCDR Measure
NQF ID Number (if applicable):
N/A
High Priority Type:
N/A
Measure Type:
Process
NQS Domain:
Effective Clinical Care
Inverse Measure?
No
Proportional Measure?
Yes
Continuous Variable Measure?
No
Ratio Measure?
No
Number of performance rates to be calculated and submitted in the XML:
1
Risk-Adjusted?
No
If risk-adjusted, indicate which score is risk-adjusted:
N/A
Measure Description:
The percentage of patients with GFR<50ml/min with current H-2 blocker prescription whose dosage is within the recommended daily limits
What one meaningful measure area applies to this measure?
Medication Management
Rational:
1. Wessell AM, Litvin C, Jenkins RG, Nietert PJ, Nemeth LS, Ornstein SM. Medication prescribing and monitoring errors in primary care: a report from the Practice Partner Research Network. Qual Saf Health Care. Oct 2010;19(5):e21. https://www.ncbi.nlm.nih.gov/pubmed/20413615; 2. Manlucu J, Tonelli M, Ray JG, et al. Dose-reducing H2 receptor antagonists in the presence of low glomerular filtration rate: a systematic review of the evidence. Nephrology Dialysis Transplantation. Nov 2005;20(11):2376-2384. https://www.ncbi.nlm.nih.gov/pubmed/16091377
Denominator:
Patients with GFR < 50 ml/min with current H-2 blocker prescription
Denominator Exclusions:
None
Numerator:
Current H-2 blocker prescription within daily dose limits: for cimetidine 1200mg, famotidine 20mg, nizatidine 150mg, ranitidine 150mg
Numerator Exclusions:
None
Denominator Exceptions:
None